Accure Therapeutics, much more than a professional team

A new medicine R&D engine (R&D pharma company) operated by an experienced team dedicated to the discovery and development of new medicines to treat patient suffering from severe diseases of the central nervous system.

Our Vision, beyond values

Accure Therapeutics is committed to deliver efficiently new disease modifiers therapies to patients, i.e. new medicines able to change the course of severe orphan and non-orphan CNS diseases.
Every day is a journey of discovery

A successful business model

The pharmaceutical industry discovers, develops, produces, and markets pharmaceutical drugs to be used as medications, and administered to patients in the hope...

Accure Therapeutics Team

A strong mindset to create new lines of research and to search for new treatments

Executive team

Laurent Nguyen

CEO

Pablo Villoslada

CSO

Lucia Septien-Velez de Bodinat

CMO

Paul Bikard

CFO

Team up to improve the lives of patients and relatives suffering from CNS diseases

Governance

Jose Antonio Mesa

Alta Life Sciences

Montse Vendrell

Alta Life Sciences

Pascal R.G. Nizet

Life Science advisor

Teresa Tarragó

Biotech Entrepreneur

Laurent Nguyen

CEO

Paul A. Frohna

Independent Board Member

Our Partners

* This company is capitalized by Innvierte, an investment program of CDTI, E.P.E.

Download our corporate presentation

Download